Patient Name : VANSHAJ MONGIA Lab No.

: PSV22045835
Age / Sex : 15 Y / M Registration On : 05-04-2022
Referred By : SELF Collection Date : 05/Apr/2022 02:30PM
Patient ID : UHOM.0000030303 Received Date : 05/Apr/2022 07:53PM
Centre : BTC PASCHIM VIHAR Approved Date : 05/Apr/2022 09:58PM

Test Name Result Biological Ref. Interval Method

Liver Function Test , Serum

Total Protein 6.5 g/dL 6.5-8.2 Biuret, No Serum Blank
Albumin 4.1 g/dL 4.1 - 5.1 Bromocresol Green
Globulin 2.4 gm/dL 2.0-3.5 Calculated
A/G Ratio 1.71 Ratio 1.5-2.5 Calculated
Total Bilirubin 0.49 mg/dL 0.2-1.3 Azobilirubin/dyphylline
Conjugated Bilirubin 0.33 mg/dL <0.3 Calculated
Unconjugated Bilirubin 0.16 mg/dL <1.1 Spectrophotometry
SGOT (AST) 93 U/L 18 - 36 Enzymatic Colorimetric
SGPT (ALT) 79 U/L 4-50 UV with P5P
SGOT/SGPT Ratio 1.18 Ratio Calculated
Alkaline Phosphatase 163 U/L 113 - 438 PNPP, AMP buffer
Gamma Glutamyl Transferase 37 U/L 10 - 33 G-glutamyl-p-nitroanilide

-----------------------------------------------------------------------------------------------------------------
The laboratory is NABL Accredited for tests in LFT
-----------------------------------------------------------------------------------------------------------------
Technology: Dry Chemistry (VITROS MicroSlide, MicroSensor and Intellicheck Technology)
---------------------------------------------------------------------------------------------------------------------
Sample Type: Serum
Analyzer: Fully Automated Biochemistry and ImmunoAssay Analyzer: VITROS 5600
---------------------------------------------------------------------------------------------------------------------
Clinical Significance of LFT: The clinical suspicion of liver disease usually leads to the measurement of the liver function tests (LFT) which include measurement of several enzymes, serum bilirubin and albumin. These parameters may
point to an underlying pathological process and direct further investigation. The aim of investigation in patients with suspected liver disease are:
ꞏ To detect hepatic abnormality ꞏ Measurement of severity of liver damage ꞏ Identify the specific cause
ꞏ Investigate possible complications
---------------------------------------------------------------------------------------------------------------------
Remarks: Please correlate clinically.
---------------------------------------------------------------------------------------------------------------------

*** End Of Report ***

Scan to Validate Report Page 1 of 4

SIN No:CL00640031

HOD Healthcare Pvt. Ltd., A-3/269, Paschim Vihar, West Delhi, Delhi 110063
Patient Name : VANSHAJ MONGIA Lab No. : PSV22045835
Age / Sex : 15 Y / M Registration On : 05-04-2022
Referred By : SELF Collection Date : 05/Apr/2022 02:30PM
Patient ID : UHOM.0000030303 Received Date : 05/Apr/2022 07:53PM
Centre : BTC PASCHIM VIHAR Approved Date : 05/Apr/2022 09:58PM

Test Name Result Biological Ref. Interval Method

C-Reactive Protein , Serum

CRP [Quantitative] 35.8 mg/L <5.0 Immunoturbidimetric

-------------------------------------------------------------------------------------------------------------------
Clinical Significance of CRP:
C-reactive protein (CRP) is a serum protein, which issynthesized in the liver. Its rate of synthesis and secretion increases within hours of an acute injury or the onset of inflammation and may reach as high as 20 times the normal levels.
Elevated serum concentration of CRP indicates active tissue damage process and CRP measurement thus provides a simple screening test for organic disorders. Clinical Significance of CRP stands important for
- Inflammatory disorders
- Management of neonatal septicaemia and meningitis
- Postoperative surveillance
- Myocardial infarction
- CRP is found to be present after the first trimester of pregnancy and persists until delivery.
- CRP levels increase in women who are on oral contraceptives.
- CRP response is not affected by the commonly used anti-inflammatory or immunosuppressive drugs, including steroids, unless the disease activity is affected.
Advise for CRP:
Since CRP production is a non-specific response to tissue injury, it is recommended that results of the test should be correlated with clinical findings to arrive at the final diagnosis. In cases where an increase in CRP levels is suspected,
but the screening tests shows negative results, semiquantitation should be done to rule out prozone effect.
---------------------------------------------------------------------------------
Sample Type: Serum
Technology: VITROS MicroTip, MicroSensor & Intellicheck
Analyzer: Fully Automated Biochemistry and Immunology Analyzer : VITROS 5600
---------------------------------------------------------------------------------
Advise: Please correlate results with clinical conditions
---------------------------------------------------------------------------------

*** End Of Report ***

Scan to Validate Report Page 2 of 4

SIN No:CL00640031

HOD Healthcare Pvt. Ltd., A-3/269, Paschim Vihar, West Delhi, Delhi 110063
Patient Name : VANSHAJ MONGIA Lab No. : PSV22045835
Age / Sex : 15 Y / M Registration On : 05-04-2022
Referred By : SELF Collection Date : 05/Apr/2022 02:30PM
Patient ID : UHOM.0000030303 Received Date : 05/Apr/2022 07:53PM
Centre : BTC PASCHIM VIHAR Approved Date : 05/Apr/2022 09:58PM

Test Name Result Biological Ref. Interval Method

CBC , EDTA Whole Blood

Hemoglobin 11.6 gm/dL 13.0 - 17.0 Photometric Measurement
Total RBC 6.91 million/µL 4.5 - 5.5 Coulter Principle
Platelet Count 165 X 10³ / µL 150 - 410 x 10³/µL Coulter Principle
Total Leucocyte Count (WBC) 2.5 X 10³ / µL 4.0 - 10.0 Coulter Principle
Differential Leucocyte Count (DLC)
Neutrophils 58 % 40 - 80 VCSn/Microscopy
Lymphocytes 35 % 20 - 40 VCSn/Microscopy
Monocytes 06 % 2 - 10 VCSn/Microscopy
Eosinophils 01 % 1-6 VCSn/Microscopy
Basophils 00 % 0-1 VCSn/Microscopy
Absolute Neutrophil Count 1.45 X 10³ / µL 2.0 - 7.5 VCSn/Microscopy
Absolute Lymphocyte Count 0.88 X10³ / µL 1.0 - 4.0 VCSn/Microscopy
Absolute Monocyte Count 0.15 X 10³ / µL 0.2 - 1.0 VCSn/Microscopy
Absolute Eosinophil Count 0.03 X 10³ / µL 0.02 - 0.5 VCSn/Microscopy
Absolute Basophil Count 0.01 X10³ / µL 0.00 - 0.30 VCSn/Microscopy
Indices
Hematocrit 37.0 % 40 - 50 Calculated
Mean Corpuscular Volume (MCV) 53.5 fL 83 - 101 Calculated
Mean Corp. Hemoglobin (MCH) 16.8 pg 27 - 32 Calculated
MCH Concentration (MCHC) 31.5 g/dl 31.5 - 34.5 Calculated
Red Cell Dist. Width (RDW-CV) 17.7 % 11.5 - 14.0 Calculated
Red Cell Dist. Width (RDW-SD) 33.7 fL 39 - 46 Calculated
Mean Platelet Volume (MPV) 8.7 fL 7-5 - 12.0 Calculated
Neutrophil-Lymphocyte Ratio (NLR) 1.66 Calculated

-----------------------------------------------------------------------------------------------------------------
Remarks: Please correlate with clinical conditions.
-----------------------------------------------------------------------------------------------------------------

*** End Of Report ***

Scan to Validate Report Page 3 of 4

SIN No:ED00336545

HOD Healthcare Pvt. Ltd., A-3/269, Paschim Vihar, West Delhi, Delhi 110063
Patient Name : VANSHAJ MONGIA Lab No. : PSV22045835
Age / Sex : 15 Y / M Registration On : 05-04-2022
Referred By : SELF Collection Date : 05/Apr/2022 02:30PM
Patient ID : UHOM.0000030303 Received Date : 05/Apr/2022 07:53PM
Centre : BTC PASCHIM VIHAR Approved Date : 05/Apr/2022 09:17PM

Test Name Result Biological Ref. Interval Method

Dengue NS1 , Serum

Dengue NS1 Antigen Negative

--------------------------------------------------------------------------------------------------
Interpretation:
Interpretation Remarks
No detectable Dengue NS1. The result does not rule our dengue infection. An additional sample for IgG and IgM ishould be tested after 7-14
Negative
days.
Equivocal Repeat Sample after 1 Week
Presence of detectable NS1 Antigen. Dengue IgG and IgM Assay Should Be Performed after 5-7 days of onset of fever, to confirm dengue
Positive
infecton
--------------------------------------------------------------------------------------------------
Clinical Advise: For the first 5 days of fever, advised screening test is Dengue NS1 Antigen, After 7-10 of fever onset, the receommended screening test is Dengue IgG
and IgM Serology.
--------------------------------------------------------------------------------------------------
Advise: Please note that this is a screening test only. Advised confirmation with Dengue by PCR for further diagnosis.
--------------------------------------------------------------------------------------------------
Please correlate results clinically.
--------------------------------------------------------------------------------------------------

Typhidot IgM
Typhi Dot (IgM) Negative

-------------------------------------------------------------------------------------
Clinical Significance :-
(1) TyphiDot (IgM) measures recent infection.
(2) These tests are intended to be used as screening test. Positive test must be Confirmed with confirmatory testing method(s).
(3) Specimens containing unusually high titre of heterophile antibodies or RA factor may give false positive results.
(4) A negative result indicates absence of detectable antibodies. However, a negative test does not rule out S.Typhi.
-------------------------------------------------------------------------------------
Please correlate results clinically.
-------------------------------------------------------------------------------------

*** End Of Report ***

In case of any discrepancy due to typing error, kindly get it rectified immediately.This is professional opinion, not a diagnosis.

Scan to Validate Report Page 4 of 4

SIN No:SE00071674

HOD Healthcare Pvt. Ltd., A-3/269, Paschim Vihar, West Delhi, Delhi 110063
Experience Care

Conditions Of Reporting
The report results are for information and interpretation for your referring doctor. Reports are to be
correlated with the patient’s clinical history.

Biological Reference Range/Interval is suggested for your Gender and Age on the basis of available
literature. All reference ranges are to be reconsidered by physician’s advice for your specific care.

This Medical Report is a professional opinion, not a diagnosis.

The report will carry the name and age provided at the time of registration. To maintain confidentiality,
certain reports may not be e-mailed at the discretion of the management.

All the notes and interpretation beneath the pathology result in the report provided are for educational
purpose only. It is not intended to be a substitute for physician's consultation.

Results of tests may vary from laboratory to laboratory and in some parameters from time to time for the
same patients. Test results and reference range may also vary depending on the technology and
methodology used. Laboratory test results may also vary depending on the age, sex, time of the day
sample has been taken, diet, medication and limitation of modern technology.

In case of any unexpected or alarming test results, please contact us immediately for re-confirmation,
further discussion, clarifications and rectifications, if needed.

In case of any discrepancy due to typing error, kindly get it rectified immediately.

Neither HOD or its employees/representatives assume any liability or responsibility for any loss or
damage that may be incurred by any person as a result of interpreting the meaning of this report.

Test results are not valid for medico legal purposes.

In case of any issues or suggestions about your test results, please email us on
quality@houseofdiagnostics.com

The courts (forums) at Delhi shall have exclusive jurisdiction in all disputes/claims concerning the tests
and the results of the tests. Our liability is limited to the amount of investigations booked with us.

DOC#COR20200707

Facilities Available
Radiology Pathology Nuclear Medicine
3T MRI & 1.5T MRI Biochemistry India’s First Simultaneous PET-MRI
CT Scan Immunoassay Whole Body PET/CT Scan
Digital X-Ray Hematology DTPA / DMSA Renal Scans
Mammography Clinical Pathology Thyroid Scan
Open / Standing MRI Serology Whole Body Bone Scan
Bone DEXA Scan Microbiology HIDA Scan • Rest MUGA

Cardiology Investigations Neurology Investigations Dental Imaging

ECG (Electrocardiogram) EEG - ElectroEncephaloGram CBCT - Cone Beam CT Scan
Echocardiography EMG - ElectroMyoGraphy OPG - OrthoPantomoGram
TMT NCV - Nerve Conduction Velocity
Stress Echocardiography VEP - Visual Evoked Response Other Tests
Stress Thallium SSEP PFT